Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 12 August 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, and Bollinger Bands also indicate a bullish trend in both time frames. Daily moving averages confirm a bullish outlook as well. KST is bullish weekly but mildly bearish monthly, while Dow Theory shows a mildly bullish stance in both weekly and monthly evaluations. OBV is mildly bullish weekly and bullish monthly.
In terms of performance, Neurocrine has outperformed the S&P 500 over the past week (1.43% vs. 1.05%) and month (9.40% vs. 2.33%), but has underperformed on a year-to-date basis (6.71% vs. 12.22%) and over the longer terms of 3 years (37.30% vs. 70.41%) and 5 years (43.30% vs. 96.61%). Overall, the current technical indicators suggest a strong bullish sentiment.